Cargando…
GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
Patients with advanced hepatocellular carcinoma (HCC) or metastatic colorectal cancer (mCRC) have a very poor prognosis due to the lack of efficient treatments. As observed in several other tumors, the effectiveness of treatments is mainly hampered by the presence of a highly tumorigenic sub-populat...
Autores principales: | Brun, Sonia, Pascussi, Jean-Marc, Gifu, Elena Patricia, Bestion, Eloïne, Macek-Jilkova, Zuzana, Wang, Guanxiong, Bassissi, Firas, Mezouar, Soraya, Courcambeck, Jérôme, Merle, Philippe, Decaens, Thomas, Pannequin, Julie, Halfon, Philippe, Caron de Fromentel, Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364651/ https://www.ncbi.nlm.nih.gov/pubmed/34405006 http://dx.doi.org/10.7150/jca.58533 |
Ejemplares similares
-
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
por: Brun, Sonia, et al.
Publicado: (2021) -
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in
liver fibrosis through TGF-β1 inhibition
por: Bestion, Eloïne, et al.
Publicado: (2020) -
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition
por: Bestion, Eloïne, et al.
Publicado: (2022) -
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors
por: Bestion, Eloïne, et al.
Publicado: (2023) -
Cell and Animal Models for SARS-CoV-2 Research
por: Bestion, Eloïne, et al.
Publicado: (2022)